These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 6189287

  • 1. Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants.
    Graves PN, Schulman JL, Young JF, Palese P.
    Virology; 1983 Apr 15; 126(1):106-16. PubMed ID: 6189287
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
    Russ G, Poláková K, Kostolanský F, Styk B, Vancíková M.
    Acta Virol; 1987 Sep 15; 31(5):374-86. PubMed ID: 2891276
    [Abstract] [Full Text] [Related]

  • 4. Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits.
    Sánchez-Fauquier A, Villanueva N, Melero JA.
    Arch Virol; 1987 Sep 15; 97(3-4):251-65. PubMed ID: 3322235
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains.
    Katz JM, Laver WG, White DO, Anders EM.
    J Immunol; 1985 Jan 15; 134(1):616-22. PubMed ID: 3871116
    [Abstract] [Full Text] [Related]

  • 9. Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. IV. Immunogenic properties of separated haemagglutinin glycopolypeptides.
    Styk B, Russ G, Poláková K.
    Acta Virol; 1979 Jan 15; 23(1):9-20. PubMed ID: 35964
    [Abstract] [Full Text] [Related]

  • 10. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC, Jan JT, Huang YJ, Chen TH, Wu SC.
    J Virol; 2016 Oct 01; 90(19):8496-508. PubMed ID: 27440889
    [Abstract] [Full Text] [Related]

  • 11. Antigenic determinants of influenza virus haemagglutinin. VI. Antigenic characterization of the oligosaccharide sidechains form HA1 of influenza virus haemagglutinins.
    Jackson DC, Brown LE, White DO.
    J Gen Virol; 1981 Jan 01; 52(Pt 1):163-8. PubMed ID: 6167660
    [Abstract] [Full Text] [Related]

  • 12. Diversity of the antibody response to the different antigenic determinants on the hemagglutinin subunits of influenza viruses.
    Laver WG, Downie JC, Webster RG.
    J Immunol; 1976 Feb 01; 116(2):336-41. PubMed ID: 55438
    [Abstract] [Full Text] [Related]

  • 13. Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin.
    Atassi MZ, Webster RG.
    Proc Natl Acad Sci U S A; 1983 Feb 01; 80(3):840-4. PubMed ID: 6187004
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S, Loving CL, Manischewitz J, King LR, Gauger PC, Henningson J, Vincent AL, Golding H.
    Sci Transl Med; 2013 Aug 28; 5(200):200ra114. PubMed ID: 23986398
    [Abstract] [Full Text] [Related]

  • 18. Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera.
    Styk B, Russ G, Poláková K.
    Acta Virol; 1979 Jan 28; 23(1):1-8. PubMed ID: 35954
    [Abstract] [Full Text] [Related]

  • 19. Mouse H-2k-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin.
    Gould KG, Scotney H, Townsend AR, Bastin J, Brownlee GG.
    J Exp Med; 1987 Sep 01; 166(3):693-701. PubMed ID: 2442286
    [Abstract] [Full Text] [Related]

  • 20. Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin.
    Simeckova-Rosenberg J, Yun Z, Wyde PR, Atassi MZ.
    Vaccine; 1995 Jul 01; 13(10):927-32. PubMed ID: 7483766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.